A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population

Target ArticleEdit

A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population; S Livadas, M Dracopoulou, C Lazaropoulouae; 2009; doi_citing_unknown

RetractionEdit

Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia due to classic 11ß-hydroxylase deficiency  ; Firdevs Bas Nucin Saka Feyza Darendeliler Siki Tuzlah Ridvan Ilhan Ruveyde Bundak Hulya Gonuz; 06/01/2000

https://doi.org/0.1515/JPEM.2000.13.6.663

Citation pieceEdit

Note: Open to append information.